Atabak Mokari

Chief Financial Officer

Atabak Mokari (Chief Financial Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Corcept Therapeutics Incorporated (CORT). The largest single filing was $9.1M of CORT (79,000 sh across 11 lots, as filed), executed Jul 30.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 4 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$18.6M

shares × price, as filed

Last traded

Jul 30

Filed Aug 3

Median ADV $130.9M across their filed names

Open performance→

Volume by month

Buys $0 Sells $18.6M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 4 filings

Sector per market data · by filing · past 12 months

Most traded names

CORT

Corcept Therapeutics Incorporated CORT · 0 buys · 4 sells 4 filings

Recent filings

CORTSALE Corcept Therapeutics Incorporated View filing → $9.1M
79,000 sh across 11 lots
Exec Jul 30
Filed Aug 3 · 4:30 PM ET CORTSALE Corcept Therapeutics Incorporated View filing → $3.5M
39,899 sh across 3 lots
Exec Jul 15
Filed Jul 17 · 6:31 PM ET CORTSALE Corcept Therapeutics Incorporated View filing → $3.2M
39,998 sh across 3 lots
Exec Jun 15
Filed Jun 17 · 5:30 PM ET CORTSALE Corcept Therapeutics Incorporated View filing → $2.8M
40,000 sh × $70.00
Exec Jun 1
Filed Jun 3 · 5:30 PM ET